Xueli Bian

2.2k citations
15 papers · 1.4k indexed · 1 hit paper · h-index 9
Topics
Cancer, Hypoxia, and Metabolism (5 papers)Cancer, Lipids, and Metabolism (4 papers)Ferroptosis and cancer prognosis (4 papers)

In The Last Decade

Xueli Bian

13 papers receiving 1.4k citations

Hit Papers

Lipid metabolism and cancer20202026202220242020200400600

Peers

Xueli Bian
Comparison fields: 5 of 89
  • Molecular Biology 902
  • Cancer Research 792
  • Pulmonary and Respiratory Medicine 207
  • Immunology 194
  • Oncology 169
Replace Shu‐Wing Ng with:
Shu‐Wing Ng United States
Ibtissam Marchiq France
Yanhua Zheng China
Guishuai Lv China
Evan C. Lien United States
Jérôme Durivault France
Yekaterina Y. Zaytseva United States
Zheqiong Tan China
Alexandra Grassian United States
Linchong Sun China
Xueli Bian relative to Shu‐Wing Ng United States Shu‐Wing Ng's profile →
Citations per field
00.5×2.9×
Shu‐Wing Ng · 1×
Citations per year

Countries citing papers authored by Xueli Bian

Since Specialization
Citations

This map shows the geographic impact of Xueli Bian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xueli Bian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xueli Bian more than expected).

Fields of papers citing papers by Xueli Bian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xueli Bian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xueli Bian. The network helps show where Xueli Bian may publish in the future.

Co-authorship network of co-authors of Xueli Bian

This figure shows the co-authorship network connecting the top 25 collaborators of Xueli Bian. A scholar is included among the top collaborators of Xueli Bian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xueli Bian. Xueli Bian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 0
2 0
3 6
4 4
5 7
6 6
7 138
8 96
9 13
10 158
11 16
12
Lipid metabolism and cancerbreakdown →
629
13 180
14 111
15 24

About Xueli Bian

Xueli Bian is a scholar working on Cancer Research, Physiology and Molecular Biology, having authored 15 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (5 papers), Cancer, Lipids, and Metabolism (4 papers) and Ferroptosis and cancer prognosis (4 papers). The work is most often cited by research in Cancer Research (792 citations), Molecular Biology (902 citations) and Biochemistry (92 citations). Xueli Bian has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Zhimin Lu, Ying Meng, Daqian Xu, Rui Liu, Dongming Xing, Fei Shao, Hongfei Jiang, Tingbo Liang, Jing Fang and Hang‐zi Chen. Their work appears in journals such as Nature Communications, The Journal of Experimental Medicine and Molecular Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026